Purchase of 53,613 shares at $10.64 per share.
Reporting Person Hayden Michael R · Transaction Code P
Traded Aug 24, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001628280-26-058684 · filed 2026-08-24 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "AbCellera Biologics Inc. (ABCL)." Disclosed 2026-08-24. https://desqlong.com/cards/0001628280-26-058684-1 (retrieved 2026-09-26).